Sign in
Taking peopleNo phase

Two drilling methods during CARTISTEM stem cell surgery for knee cartilage damage

Compares two bone drilling techniques with CARTISTEM in people with knee cartilage defects.

Key facts

Who runs it
Yonsei University
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Subchondral Drilling Diameter During CARTISTEM Implantation for Knee Cartilage Defects
Status
Recruiting
People taking part
60 people, planned
Started
13 Jul 2026
Expected to end
19 Feb 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 2-mm subchondral drilling
  • Sequential 4-mm and 2-mm subchondral drilling
Record updated
19 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with knee pain from cartilage damage or arthritis on the inner side of the knee who will have CARTISTEM stem cell implantation. It compares two ways of drilling small holes in the bone under the cartilage.

Age
19 years or older
Sex
All sexes
Disease stage
Cartilage damage or arthritis on the inner (medial) side of the knee, confirmed by imaging and judged to be the main cause of symptoms. Grade IV (Kellgren-Lawrence) osteoarthritis cannot join.
Earlier treatment
Knee pain for at least 3 months despite conservative treatment, such as medication or physical therapy. CARTISTEM implantation must already be decided. No knee cartilage surgery within 1 year before screening.

Main reasons for not taking part

  • Loose knee ligaments that need ligament surgery at the same time
  • Bow-legged alignment of 5 degrees or more, unless corrected by high tibial osteotomy (a bone-realigning surgery) at the same time
  • Autoimmune or inflammatory arthritis, such as rheumatoid arthritis
  • Unable to have an MRI scan
  • Body mass index of 35 kg/m² or more

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age 19 years or older
  • Knee pain for at least 3 months despite conservative treatment, including medication or physical therapy
  • Medial-compartment knee arthritis or articular cartilage defects judged to be the main cause of symptoms
  • Imaging-confirmed medial-compartment cartilage defects for which CARTISTEM implantation has been decided
  • Voluntary written informed consent by the participant or legally authorized representative after understanding the study

Who cannot take part

  • Surgery for knee cartilage injury within 1 year before screening
  • Ligament instability requiring simultaneous ligament surgery
  • Autoimmune or inflammatory arthritis, including rheumatoid arthritis
  • Age younger than 19 years
  • Kellgren-Lawrence grade IV osteoarthritis on weight-bearing anteroposterior knee radiographs
  • Mechanical-axis varus deformity of 5 degrees or greater, unless corrected by simultaneous high tibial osteotomy
  • Inability to undergo MRI
  • Body mass index of 35 kg/m² or greater
  • Inability to adequately understand the study explanation, including illiteracy or a language barrier

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective, randomized study at Severance Hospital compares two subchondral drilling techniques during CARTISTEM implantation for symptomatic medial-compartment knee articular cartilage defects. Sixty participants will be allocated 1:1 to drilling with a 2-mm drill alone or sequential drilling with 4-mm and 2-mm drills. CARTISTEM preparation and implantation will be the same in both groups. High tibial osteotomy may be performed when needed to correct alignment.

Read full original descriptionShow less

The primary endpoint is the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation score at 12 months after surgery. The study will assess non-inferiority of the 2-mm technique using a prespecified margin of 10.3 points. Secondary assessments include pain and knee function, MRI cartilage repair and subchondral bone findings, radiographic osteoarthritis and alignment, and second-look arthroscopy in participants undergoing plate removal after high tibial osteotomy.

The 2 groups in the trial

  • 2-mm subchondral drillingTreatment being tested

    Subchondral drilling with a 2-mm drill alone, followed by CARTISTEM implantation. High tibial osteotomy may be performed when needed for alignment correction.

  • Sequential 4-mm and 2-mm subchondral drillingExisting treatment, for comparison

    Sequential subchondral drilling with 4-mm and 2-mm drills, followed by the same CARTISTEM preparation and implantation. High tibial osteotomy may be performed when needed.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparative Analysis of Clinical Outcomes According to Subchondral Bone Drilling Diameter in Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell (Cartistem®) Implantation for Knee Articular Cartilage Defects
Plain-language title
Two drilling methods during CARTISTEM stem cell surgery for knee cartilage damageGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
19 October 2026